PureTech Health (PRTC) Non-Current Assets (2019 - 2025)
PureTech Health (PRTC) reported Non-Current Assets of $229.7 million for Q4 2025, up 6.15% year-over-year from $216.4 million in Q4 2024, and up 9.98% on a QoQ basis from $208.9 million in Q2 2025.
PureTech Health (PRTC) has 6 years of Non-Current Assets data on file, last reported at $229.7 million in Q4 2025.
- Quarterly Non-Current Assets rose 6.15% year-over-year to $229.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $229.7 million (up 6.15% YoY) and the FY2025 annual result came in at $229.7 million, up 6.15% from the prior year.
- Non-Current Assets advanced to $229.7 million in Q4 2025 per PRTC's latest filing, from $208.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $444.2 million in Q4 2021 and bottomed at $208.9 million in Q2 2025.
- The 4-year median for Non-Current Assets is $229.7 million (2025), against an average of $283.1 million.
- The widest annual swing landed in 2022, when Non-Current Assets fell 28.76%; it then advanced 6.15% in 2025.
- Tracing PRTC's Non-Current Assets over 4 years: stood at $444.2 million in 2021, then slipped by 28.76% to $316.5 million in 2022, then sank by 31.62% to $216.4 million in 2024, then rose by 6.15% to $229.7 million in 2025.
- Per Business Quant, the three latest PRTC Non-Current Assets figures stand at $229.7 million (Q4 2025), $208.9 million (Q2 2025), and $216.4 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 22.66 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 910.24 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 229.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 229.69 Mn |
| Jun 30, 2025 | 208.85 Mn |
| Dec 31, 2024 | 216.38 Mn |
| Dec 31, 2022 | 316.45 Mn |
| Dec 31, 2021 | 444.20 Mn |
| Dec 31, 2020 | 575.65 Mn |
| Dec 31, 2019 | 772.33 Mn |